<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MolSight: Optical Chemical Structure Recognition with SMILES Pretraining, Multi-Granularity Learning and Reinforcement Learning - Health AI Hub</title>
    <meta name="description" content="MolSight introduces a novel, three-stage learning framework for Optical Chemical Structure Recognition (OCSR), specifically addressing the critical challenge of">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>MolSight: Optical Chemical Structure Recognition with SMILES Pretraining, Multi-Granularity Learning and Reinforcement Learning</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.17300v1" target="_blank">2511.17300v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-21
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Wenrui Zhang, Xinggang Wang, Bin Feng, Wenyu Liu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.17300v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.17300v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">MolSight introduces a novel, three-stage learning framework for Optical Chemical Structure Recognition (OCSR), specifically addressing the critical challenge of accurately recognizing subtle stereochemical information. By integrating SMILES pretraining, multi-granularity fine-tuning with auxiliary tasks, and reinforcement learning optimization, the system achieves state-of-the-art performance in converting chemical structure images into machine-readable representations. This advancement significantly enhances capabilities crucial for large-scale chemical data mining and drug discovery pipelines.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate and automated Optical Chemical Structure Recognition, especially for stereochemical information, is paramount in drug discovery and development. It enables the efficient conversion of vast amounts of chemical data from scientific literature and patents into machine-readable formats, which is essential for large-scale data mining, screening for potential drug candidates, and integrating with advanced AI tools and Large Language Models in pharmaceutical research.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>MolSight is an AI-powered system (using SMILES pretraining, multi-granularity learning, and reinforcement learning) designed for automated conversion of chemical structure images into machine-readable formats. This AI application serves as a foundational tool for accelerating various aspects of drug discovery and development, including: 1) enabling large-scale analysis and mining of chemical data from scientific literature and patents, which is crucial for identifying potential drug candidates, and 2) facilitating the development of other AI tools (e.g., LLMs) in pharmaceutical research.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>MolSight addresses the significant challenge in OCSR of accurately recognizing stereochemical information, which is critical for distinguishing stereoisomers.</li>
                    
                    <li>The framework employs a three-stage training paradigm: pre-training on large-scale datasets, multi-granularity fine-tuning, and reinforcement learning for post-training optimization.</li>
                    
                    <li>SMILES pretraining endows the model with fundamental perception capabilities for chemical structure images, leveraging a common machine-readable format.</li>
                    
                    <li>Multi-granularity fine-tuning incorporates auxiliary tasks, specifically chemical bond classification and atom localization, to systematically improve molecular formula recognition.</li>
                    
                    <li>Reinforcement learning, using the Group Relative Policy Optimization (GRPO) algorithm, is applied for post-training, and a novel stereochemical structure dataset was introduced during this stage.</li>
                    
                    <li>Remarkably, GRPO significantly enhances the model's performance on stereomolecules, even with MolSight's relatively compact parameter size.</li>
                    
                    <li>MolSight achieves state-of-the-art performance across diverse datasets in both chemical and stereochemical optical structure recognition.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>MolSight utilizes a comprehensive three-stage learning framework. The first stage involves pre-training on large-scale, potentially noisy datasets to establish fundamental chemical image perception, likely incorporating SMILES representations. The second stage consists of multi-granularity fine-tuning using datasets with richer supervisory signals, integrating auxiliary tasks such as chemical bond classification and atom localization to enhance molecular formula recognition. The final stage employs reinforcement learning for post-training optimization, specifically leveraging the Group Relative Policy Optimization (GRPO) algorithm, and introduces a novel stereochemical structure dataset to specifically target the complexities of stereomolecular recognition.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>MolSight achieves state-of-the-art performance in both general chemical and complex stereochemical optical structure recognition across a variety of diverse datasets. A particularly notable finding is that the Group Relative Policy Optimization (GRPO) algorithm significantly boosts the model's accuracy on stereomolecular structures, demonstrating its effectiveness even when applied to a model with a relatively compact parameter size.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology can profoundly impact clinical and pharmaceutical development by significantly accelerating the initial phases of drug discovery. By providing highly accurate and automated recognition of chemical structures, including nuanced stereochemical details, MolSight facilitates faster and more reliable chemical data mining, improved design of novel drug candidates, and efficient management of chemical libraries. This leads to a streamlined pipeline for identifying, characterizing, and optimizing potential therapeutic agents, ultimately reducing development timelines and costs in bringing new medicines to market.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the MolSight framework or its performance under specific challenging conditions.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention specific future research directions for MolSight or the broader field of OCSR.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmaceutical Research and Development</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Computational Chemistry</span>
                    
                    <span class="tag">Pharmacoinformatics</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Biomedical Data Science</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Optical Chemical Structure Recognition (OCSR)</span>
                    
                    <span class="tag tag-keyword">Stereochemistry</span>
                    
                    <span class="tag tag-keyword">SMILES Pretraining</span>
                    
                    <span class="tag tag-keyword">Multi-Granularity Learning</span>
                    
                    <span class="tag tag-keyword">Reinforcement Learning (RL)</span>
                    
                    <span class="tag tag-keyword">Drug Discovery</span>
                    
                    <span class="tag tag-keyword">Chemical Informatics</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Optical Chemical Structure Recognition (OCSR) plays a pivotal role in modern chemical informatics, enabling the automated conversion of chemical structure images from scientific literature, patents, and educational materials into machine-readable molecular representations. This capability is essential for large-scale chemical data mining, drug discovery pipelines, and Large Language Model (LLM) applications in related domains. However, existing OCSR systems face significant challenges in accurately recognizing stereochemical information due to the subtle visual cues that distinguish stereoisomers, such as wedge and dash bonds, ring conformations, and spatial arrangements. To address these challenges, we propose MolSight, a comprehensive learning framework for OCSR that employs a three-stage training paradigm. In the first stage, we conduct pre-training on large-scale but noisy datasets to endow the model with fundamental perception capabilities for chemical structure images. In the second stage, we perform multi-granularity fine-tuning using datasets with richer supervisory signals, systematically exploring how auxiliary tasks-specifically chemical bond classification and atom localization-contribute to molecular formula recognition. Finally, we employ reinforcement learning for post-training optimization and introduce a novel stereochemical structure dataset. Remarkably, we find that even with MolSight's relatively compact parameter size, the Group Relative Policy Optimization (GRPO) algorithm can further enhance the model's performance on stereomolecular. Through extensive experiments across diverse datasets, our results demonstrate that MolSight achieves state-of-the-art performance in (stereo)chemical optical structure recognition.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>